Timothy and Peggy Ann Plaugher have filed a lawsuit in U.S. District Court for the Western District of Louisiana against Takeda Pharmaceuticals and Eli Lilly & Co. that alleges the type 2 diabetes drug Actos caused Timothy’s bladder cancer.
According to the lawsuit, Plaugher’s bladder cancer is a direct result of taking the “unreasonably dangerous and defective drug,” Actos. The suit also says that Takeda knew or should have known about the increased risks of bladder cancer when used by patients for more than 12 months. <!–more–>
Allegations in the lawsuit also include that Takeda concealed information that showed statistically significant higher percentages of bladder cancer in patients taking Actos, and that Takeda “willfully, wantonly and with malice withheld the knowledge of increased risk of cancer of Actos to prevent any chances of its products’ registrations being delayed or rejected by the FDA.”
The lawsuit seeks damages of an amount in excess of $75,000, economic losses, attorneys’ fees, reimbursement of costs of obtaining Actos, reimbursement for all past, present, and future health and medical care costs related to Actos.